Suono Bio Overview

  • Founded
  • 2015
Founded
  • Status
  • Private
  • Employees
  • 8
Employees
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $12.2M
Latest Deal Amount
  • Investors
  • 12

Suono Bio General Information

Description

Developer of a targeted drug delivery platform designed to facilitate rapid, localized delivery of small molecules, biologics, nucleic acids and gene therapies without the need for encapsulation of the therapeutic. The company's platform enables ultra-rapid delivery of therapies and macromolecules across tissues including biologics and nucleic acids that are delivered directly into the gastrointestinal tissues with small molecules, proteins, vaccines, and nucleic acids, enabling patients to recover from gastrointestinal diseases more efficiently.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Delivery
Other Industries
Drug Discovery
Therapeutic Devices
Primary Office
  • 501 Massachusetts Avenue
  • Cambridge, MA 02139
  • United States
+1 (617) 000-0000

Suono Bio Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Suono Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series A) 07-Jul-2021 $12.2M 000.00 000.00 Completed Generating Revenue
5. Grant 01-Jan-2019 00000 00.00 Completed Generating Revenue
4. Early Stage VC (Series A) 19-Sep-2017 00.00 00.00 00.00 Completed Generating Revenue
3. Accelerator/Incubator 13-Oct-2016 Completed Generating Revenue
2. Accelerator/Incubator 01-Jan-2016 Completed Generating Revenue
1. Accelerator/Incubator 01-Jan-2015 Completed Startup
To view Suono Bio’s complete valuation and funding history, request access »

Suono Bio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.00
Series A NV 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
To view Suono Bio’s complete cap table history, request access »

Suono Bio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a targeted drug delivery platform designed to facilitate rapid, localized delivery of small molecules, biol
Drug Delivery
Cambridge, MA
8 As of 2021
000.00
00.00 0000-00-00
00000000000 000.00

0000000

e magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip e
0000000000000
Cambridge, MA
00 As of 0000
0000
000 0000-00-00
00000000000 0000

0000000

minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Dui
0000000000000
Berkeley, CA
00 As of 0000
000.00
00.00 0000-00-00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Suono Bio Competitors (7)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Celsius (Biotechnology) Venture Capital-Backed Cambridge, MA 00 0000 00000000000 0000
0000000 0000000000 Venture Capital-Backed Berkeley, CA 00 000.00 00000000000 000.00
00000 00000 000000 Venture Capital-Backed Geneva, Switzerland 00 00000 0000000000 0 00000
00 000000000000 Venture Capital-Backed Woburn, MA 00 000.00 00000000000 000.00
000000 Venture Capital-Backed Seattle, WA 00 000.00 0000000000 0 000.00
You’re viewing 5 of 7 competitors. Get the full list »

Suono Bio Executive Team (6)

Name Title Board Seat Contact Info
Scott Kellogg Chief Executive Officer & Board Member
Carl Schoellhammer Ph.D Co-Founder, Chief Technology Officer, President & Board Member
Albert Farinha Chief Operating Officer
Giovanni Traverso Ph.D Co-Founder & Board Member
Robert Langer Co-Founder & Board Member
You’re viewing 5 of 6 executive team members. Get the full list »

Suono Bio Board Members (7)

Name Representing Role Since
Amy Schulman JD Self Co-Founder & Board Member 000 0000
Carl Schoellhammer Ph.D Suono Bio Co-Founder, Chief Technology Officer, President & Board Member 000 0000
Frederick Shane Suono Bio Board Member 000 0000
Giovanni Traverso Ph.D Self Co-Founder & Board Member 000 0000
Robert Langer Self Co-Founder & Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

Suono Bio Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Suono Bio Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Axil Capital Partners Venture Capital Minority 000 0000 000000 0
Gutbrain Ventures Venture Capital Minority 000 0000 000000 0
Mizuho Securities Investment Bank Minority 000 0000 000000 0
Taiwania Capital Venture Capital Minority 000 0000 000000 0
National Institutes of Health Government 000 0000 000000 0
You’re viewing 5 of 12 investors. Get the full list »